One of our Directors, David Heal, was co-author of this new article 'Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling' which is now available online as part of a Special Issue of Neuropharmacology (National Institutes of Health Psilocybin Research Speaker Series) edited by David Heal, Jack Henningfield, Sharon Smith and Sean Belouin.
You can read the paper here and find out more about the Special Issue of Neuropharmacology here